ESR1 and breast cancer: All were intrachromosomal events and two of three fusions were occurred in ligand binding domain of ESR1. In the TCGA PanCancer Atlas Project, fusions affecting ESR1 were infrequent in BC (0.8%), and counterpart genes varied27.